Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-18.62	13.89	17.06
Graham Fair Price	13.26	6.89	6.09
PEG	-22.06	0.18	0.23
Price/Book	6.62	1.02	0.96
Price/Cash Flow	42.46	-28.88	20.27
Prices/Earnings	-10.37	4.47	4.99
Price/Sales	9.58	1.01	0.92
Price/FCF	42.46	-28.88	20.27
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	31.08	0.27	0.20
Operating Margin	129.98	0.10	0.04
ROA	6.98	0.01	0.01
ROE	0.05	0.06	18.96
ROIC	0.02	0.03	55.22
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.51	0.02	1980.10
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.47	1.32	179.16
EPS QOQ	0.22	0.25	15.00
FCF QOQ	0.01	-1.78	16072.28
Revenue QOQ	< 0.005	0.01	122.09
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	78.41	93.84	19.68
Days Sales Outstanding (DSO)	73.91	62.72	-15.13
Inventory Turnover	1.15	0.96	-16.44
Debt/Capitalization	0.51	0.60	18.73
Quick Ratio	0.79	0.94	19.58
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.86	6.09	3.84
Cash	1.25	2.52	101.08
Capex	-0.41	-0.33	18.68
Free Cash Flow	0.28	-0.21	-22.28
Revenue	6.07	6.13	1.04
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.33	1.68	26.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.47	7.50	-11.41
Naive Interpretation	Member

06 - Financial Health · Weak

Rating